Table Info

Table 4.

BC staging in the years 2019, 2020, and 2021

BC stage		Early BC					Locally advanced BC					Metastatic BC		BC
Years	Age	0	IA	IIB	IIA	Total	IIB	IIIA	IIIB	IIIC	Total	IV	Total	Total
2019	40–49	2	12	0	5	19 (90.5%)	0	0	1	1	2 (9.5%)	0	0	21
	50–69	15	30	2	11	58 (82.9%)	4	2	2	2	10 (14.3%)	2	2 (2.9%)	70
	> 70	3	3	1	1	8 (57.1%)	1	0	0	0	1 (7.1%)	5	5 (35.7%)	14
2020	40–49	4	5	1	0	10 (90.9%)	0	0	1	0	1 (9.1%)	0	0	21
	50–69	11 (2*)	18 (2*)	1	6	36 (92.3%)	1	0	1	0	2 (5.1%)	1	1 (2.6%)	39
	> 70	3	2	1	3	9 (90%)	1	0	0	0	1 (10%)	0	0	10
2021	40–49	3	4 (1*)	0	1	8 (80%)	1	0	0	0	1 (10%)	1	1 (10%)	10
	50–69	10 (1*)	19 (5*)	0	2 (1*)	31 (91.2%)	1	0	1	0	2 (5.9%)	1	1 (2.9%)	34
	> 70	1	4 (1*)	0	0	5 (100%)	0	0	0	0	0	0	0	5

The value in parenthesis represents the percentage of early BC, locally advanced BC, and metastatic disease from the total of BCs diagnosed.

number of patients who refused to undergo surgery; for these patients, we considered the result of CNB and the extension of disease at breast imaging [15]

Declarations

Author contributions

DUT and RS contributed conception and design of the study; DUT organized the database; RS performed the statistical analysis; DUT and RS wrote the first draft of the manuscript. DUT, RS, and FP contributed to manuscript revision, read, and approved the submitted version.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent to publication

Not applicable.

Availability of data and materials

The datasets analyzed for this study can be found in saniarp.it, the Caserta Local Health Authority reporting database, and from the register of our daily activities.

Funding

Not applicable.

Copyright

References

I 5 tumori più frequenti in Italia nel 2019 [Internet]. Roma: Ministero della Salute; c2019 [cited 2022 Feb 25]. Available from: http://www.salute.gov.it/imgs/C_17_notizie_3897_4_file.pdf

Tari DU, Morelli L, Guida A, Pinto F. Male breast cancer review. A rare case of pure DCIS: imaging protocol, radiomics and management. Diagnostics (Basel). 2021;11:2199. [DOI] [PubMed] [PMC]

Buonomo OC, Materazzo M, Pellicciaro M, Caspi J, Piccione E, Vanni G. Tor Vergata University-Hospital in the beginning of COVID-19-era: experience and recommendation for breast cancer patients. In Vivo. 2020;34:1661–5. [DOI] [PubMed] [PMC]

Lake MA. What we know so far: COVID-19 current clinical knowledge and research. Clin Med (Lond). 2020;20:124–7. [DOI] [PubMed] [PMC]

Coronavirus disease (COVID-19) pandemic [Internet]. Geneva: World Health Organization; c2022 [cited 2022 Feb 25]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019

Covid-19 weekly monitoring, report of February 22–28, 2021 [Internet]. Ministry of Health; c2021 [cited 2022 Feb 25]. Available from: https://www.salute.gov.it/portale/nuovocoronavirus/dettaglioNotizieNuovoCoronavirus.jsp?lingua=english&menu=notizie&p=dalministero&id=5370

Rosenbaum L. Facing Covid-19 in Italy–ethics, logistics, and therapeutics on the epidemic’s front line. N Engl J Med. 2020;382:1873–5. [DOI] [PubMed]

Maio F, Tari DU, Granata V, Fusco R, Grassi R, Petrillo A, et al. Breast cancer screening during COVID-19 emergency: patients and department management in a local experience. J Pers Med. 2021;11:380. [DOI] [PubMed] [PMC]

Caplan L. Delay in breast cancer: implications for stage at diagnosis and survival. Front Public Health. 2014;2:87. [DOI] [PubMed] [PMC]

10.

Pediconi F, Galati F, Bernardi D, Belli P, Brancato B, Calabrese M, et al. Breast imaging and cancer diagnosis during the COVID-19 pandemic: recommendations from the Italian College of Breast Radiologists by SIRM. Radiol Med. 2020;125:926–30. [DOI] [PubMed] [PMC]

11.

Bleicher RJ. Timing and delays in breast cancer evaluation and treatment. Ann Surg Oncol. 2018;25:2829–38. [DOI] [PubMed] [PMC]

12.

Tari DU, Ambrosio C, Ignozzi M, Di Cerbo A. Nuovo programma di screening per il carcinoma della mammella dell’ASL Caserta: procedure diagnostiche e risultati preliminari per l’anno 2015 monitorati attraverso il portale Sani.ARP. Rass. Med. 2016;XXXII:7–18.

13.

ASL Caserta. Revisione dei GOM integrati A.O.U. “L. Vanvitelli” - A.O.R.N. “Sant” Anna e San Sebastiano di Caserta - ASL Caserta ai sensi del DCA 98 del 20.09.2016 e s.m.i. - Delibera ASL/CE n. 765 del 19.06.2020.

14.

D’Orsi CJ, Sickles EA, Mendelson EB, Morris EA. ACR BI-RADS Atlas, breast imaging reporting and data system. 5th ed. Reston, VA: American College of Radiology; 2013.

15.

Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening [Internet]. London: The Royal College of Pathologists; c2021 [cited 2022 Feb 25]. Available from: https://www.rcpath.org/uploads/assets/4b16f19c-f7bd-456c-b212f557f8040f66/G150-Non-op-reporting-breast-cancer-screening.pdf

16.

Angeli Franco, editor. 55° Rapporto sulla situazione sociale del Paese 2021. 1st ed. Censis; 2021.

17.

Gathani T, Clayton G, MacInnes E, Horgan K. The COVID-19 pandemic and impact on breast cancer diagnoses: what happened in England in the first half of 2020. Br J Cancer. 2021;124:710–2. [DOI] [PubMed] [PMC]

18.

Jacob L, Loosen SH, Kalder M, Luedde T, Roderburg C, Kostev K. Impact of the COVID-19 pandemic on cancer diagnoses in general and specialized practices in Germany. Cancers (Basel). 2021;13:408. [DOI] [PubMed] [PMC]

19.

De Vincentiis L, Carr RA, Mariani MP, Ferrara G. Cancer diagnostic rates during the 2020 ‘lockdown’, due to COVID-19 pandemic, compared with the 2018–2019: an audit study from cellular pathology. J Clin Pathol. 2021;74:187–9. [DOI] [PubMed]

20.

Kaufman HW, Chen Z, Niles J, Fesko Y. Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic. JAMA Netw Open. 2020;3:e2017267. Erratum in: JAMA Netw Open. 2020;3:e2020927. [DOI] [PubMed] [PMC]

21.

Osservatorio sulla condizione assistenziale dei malati oncologici. 11° Rapporto sulla condizione assistenziale dei malati oncologici. XIV Giornata nazionale del malato oncologico [Internet]. c2019 [cited 2022 Feb 25]. Available from: https://www.quotidianosanita.it/allegati/allegato9903144.pdf

22.

Rapporto sui ritardi accumulati dai programmi di screening Italiani in seguito alla pandemia da Covid 19. ONS; c2020 [cited 2022 Feb 25]. Available from: https://www.osservatorionazionalescreening.it/content/rapporto-sulla-ripartenza-degli-screening-dicembre-2020

23.

Vanni G, Materazzo M, Pellicciaro M, Ingallinella S, Rho M, Santori F, et al. Breast cancer and COVID-19: the effect of fear on patients’ decision-making process. In Vivo. 2020;34:1651–9. [DOI] [PubMed] [PMC]

24.

Vanni G, Materazzo M, Santori F, Pellicciaro M, Costesta M, Orsaria P, et al. The effect of coronavirus (COVID-19) on breast cancer teamwork: a multicentric survey. In Vivo. 2020;34:1685–94. [DOI] [PubMed] [PMC]

25.

Szmuda T, Özdemir C, Ali S, Singh A, Syed MT, Słoniewski P. Readability of online patient education material for the novel coronavirus disease (COVID-19): a cross-sectional health literacy study. Public Health. 2020;185:21–5. [DOI] [PubMed] [PMC]

26.

Orlando V, Guerriero F, Putignano D, Monetti VM, Tari DU, Farina G, et al. Prescription patterns of antidiabetic treatment in the elderly. Results from Southern Italy. Curr Diabetes Rev. 2015;12:100–6. [DOI] [PubMed] [PMC]

27.

Tari DU, Santarsiere A, Palermo F, Morelli CD, Pinto F. The management of a breast unit during the COVID-19 emergency: a local experience. Future Oncol. 2021;17:4757–67. [DOI] [PubMed] [PMC]

28.

Leung MST, Lin SG, Chow J, Harky A. COVID-19 and oncology: service transformation during pandemic. Cancer Med. 2020;9:7161–71. [DOI] [PubMed] [PMC]